This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EXO | Ann: Half Year Financial Report to 31 December 2018 | 28/02/19 | 0 | 248 | |||
|
|||||||
EXO | Ann: Appendix 4D Half Year Report | 28/02/19 | 0 | 88 | |||
|
|||||||
EXO | Ann: December 2018 Appendix 4C Quarterly Report | 30/01/19 | 0 | 141 | |||
|
|||||||
EXO | Ann: Results of Annual General Meeting | 12/11/18 | 0 | 173 | |||
|
|||||||
EXO | AGM next week | 09/11/18 | 1 | 307 | |||
|
|||||||
EXO | am i being robbed slowly by these shares? | 04/11/18 | 7 | 1.7K | |||
|
|||||||
EXO | Ann: September 2018 Appendix 4C Quarterly Report | 30/10/18 | 0 | 138 | |||
|
|||||||
EXO | Ann: Notice of Annual General Meeting/Proxy Form | 12/10/18 | 0 | 164 | |||
|
See All Discussions